Effective Multi-Channel Messaging Programs to Healthcare Professionals That Deliver Superior Results

Pharmaceutical Multi-channel Messaging Marketing Solutions.

Specializing in custom pharmaceutical teledetailing programs (RxReachSM), PharmaKinnex will extend the voice of your pharmaceutical brand by reaching the right audiences, with the right message through the right channels. Optimizing bottom line performance is our first priority.a professional pharmaceutical multi-channel marketing company, provides tactical services in the execution of targeted, multi-channel messaging programs.

We recognize that different customers respond to different mediums. The majority of Health Care Professionals respond optimally to some marketing mix. We develop the deepest possible customer relationships while maintaining the highest compliance standards. executing effective multi-channel messaging programs to healthcare professionals that consistently deliver superior results, for that Our supplemental or stand alone Sales Force programs offer a cost effective alternative in product detailing. Our comprehensive suite of integrated marketing support services includes TeleSales, Direct Mail, Fax and E-Marketing, Web Resource Centers and Fulfillment.

Read Original Source  Here

Customized Pharmaceutical Fulfillment Services from PharmaKinnex, NJ

New Jersey based, PharmaKinnex offers fully integrated pharmaceutical fulfillment services compliant with the regulations that govern the fulfillment of marketing materials & samples. Today, no one channel can be relied on to effectively satisfy the communication preferences of all healthcare providers. A diverse multi-channel approach works best to optimize reach and frequency and drive information and sample requests. For more information call us on: (732) 613-4422 or visit: http://pharmakinnex.com/pharmaceutical-fulfillment

PharmaKinnex Provides Integrated Pharmaceutical Fulfillment Services

PharmaKinnex provides seamless, quality, timely, pharmaceutical fulfillment services as a stand-alone service or as part of a highly-effective multi-channel marketing approach. Our fully integrated fulfillment services provide the convenience of handling your project from start to finish. Our company is founded by pharmaceutical marketing executives who know this business and understand the demands of our clients. PharmaKinnex has expert knowledge of:

• PDMA guidelines
• State license validation
• Acknowledgment of content and signature audits required for compliant Rx sample distribution.

Requests for fulfillment are customized to the recipient. Any variety of RX/OTC samples, educational and promotional items may be distributed. PharmaKinnex can fulfill:

• Direct to your pharmaceutical sales representatives
• Direct to your targeted healthcare providers, or
• Both

Call PharmaKinnex today at (732) 387-5042 to explore the features and benefits of working with one fully integrated pharmaceutical multi-channel marketing and fulfillment company.

How closing the gap between Closed-loop and Multichannel marketing can bring pharma industry together?

“Multichannel marketing” and “Closed loop marketing” can be considered as most popular terms in pharmaceutical marketing these days, while the latter being unpopular as sales reps’ enthusiasm in using interactive tablets during presentations to prescribers. In Capgemini’s new report of “Vision and Reality” series, it suggests that, by closing the long sustaining gap between MCM and CLM, we can bring pharma industry together, thanks to technology it’s the time is bring them coordinated in a structured manner.

Some definitions: Capgemini defines CLM as incorporating personalized messaging, analytics to understand how messages are received and understood, and responsiveness—the ability to “evolve the conversation” to prove that the marketer is listening to the market. MCM is simply using mulitiple channels (email, tele-detailing, face-to-face and others) to interact with customers, and to bring the results of each channels’ interactions together through analytics. CLM, which has been around for a while, has lost and then regained favor as the iPad became a preferred sales tool. But in a survey of pharma execs, Capgemini has found that even today, pharma marketers rate their maturity in a 2.0-2.5 range (on a 1-5 scale) in their ability to personalize messaging, to perform analytics and to be responsive.

As per Tim Moore, Capgemini’s life sciences group, “it is the time to alter promotional materials in response to market reactions.” As most of the pharma companies have a tendency of updating promotional strategies on quarterly or semi-annual basis; however, those using CLM successfully can reduce it to 6-8 weeks. Adding to that Hala Qanadilo, insisted on pharma companies which have their sales operations around a particular brand are already missing the efficiency of using the same CLM or MCM tools across brands, and (for some prescribers, such as general practitioners involved in many different therapies) combining knowledge about that prescriber from multiple campaigns.

There are three channel where a pharma company should put their emphasis on product (brand), channel and customer, also known as pillars of pharmaceutical marketing . You can read more about this here.

Reach Your Audience with Multi Channel Marketing- Pharmaceutical

One-dimensional promotional messaging strategies are becoming less and less effective. Pharma marketing guidelines, increased public and government scrutiny, managed care directives, and too many sales representatives have combined to create a difficult environment for delivering pharmaceutical brand messages. Here are the key benefits of having a multi-channel marketing service-

• Reach Your Audience More Consistently

• Maximize Reach and Frequency with Targeted Messaging Channels

• Improve Your Results Even More with Pharmaceutical Fulfillment and Consulting

  Read Original Content Here- http://pharmakinnex.com/multichannel-marketing

 

FDA To Survey Medical Professionals About Effects of Pharmaceutical Marketing

Source: http://www.raps.org/focus-online/news/news-article-view/article/3209/fda-gets-go-ahead-for-study-of-dtc-advertising-and-social-media.aspx

The Food and Drug Administration (FDA) has received approval from President Obama to conduct a two-year, $365,000 survey of America’s medical professionals to determine the influence of pharmaceutical marketing.  Physicians, nurse practitioners and physician assistants will be surveyed on their opinions about how drugs are marketed to consumers and healthcare providers.  The survey appears to be especially focused on direct-to-consumer (DTC) advertising and potentially social media.

Three Thoughts on the FDA Survey:

1.      If the FDA wants to understand the positive/negative influence of direct-to-consumer ads shouldn’t they also survey some consumers?  A patient who was motivated to visit their doctor about a previously untreated and potentially dangerous disease might offer a different perspective than his physician, who may have been annoyed that the patient requested or asked about a specific drug for his untreated disease.  In other words, will the doctor necessarily answer the survey in a way that sheds light on the real value of a DTC ad?

2.      Billions are spent each year in the U.S. on pharmaceutical marketing initiatives and the FDA is likely seeking to determine if these marketing programs are a negative influence on prescribing habits.  With voluntary PhRMA codes, the Sunshine Act, and other state and federal legislation, it has become much more challenging and expensive in recent years for pharmaceutical companies to market their products.  Will the FDA’s new survey lead to more regulations for pharmaceutical marketers?

3.      As government agencies seek to regulate pharmaceutical marketers it is important that they not blindly discount the value that pharmaceutical marketing brings in terms of disease awareness to physicians and patients, and education about medications that are used every day.  Certainly, there have been some abuses by pharmaceutical marketers, but these represent a tiny minority of pharmaceutical sales and marketing initiatives.  However, physicians are very busy and a short visit with a pharmaceutical sales representative or a teledetailing call can provide life-saving reminders about drug side effects and drug-to-drug interactions; And DTC drug ads can help undiagnosed or untreated patients to visit their doctor.  Does anybody believe the FDA survey will capture the benefits of pharmaceutical marketing, especially if healthcare providers are the only subjects interviewed?

Reasons why some Pharmaceutical Telemarketing Programs work, while others Fail

Many times it happens that pharmaceutical telemarketing program don’t work. It may be because of various reasons. Below is the brief overview of how we can design a successful pharmaceutical teledetailing program so that it works.

Well defined Objective: Pharmaceutical Teledetailing Program must have well defined objective. Like any marketing program if you don’t know what you want to achieve you probably aren’t going to be happy with the results.

Supportive Materials or Prescription Samples: Pharmaceutical Teledetailing Program must have Supportive Materials or Prescription Samples. If the teledetail representative doesn’t have an incentive to offer it will be a huge challenge to get a physician or nurse onto the telephone.

Multi-Channel Pharmaceutical Marketing: Pharmaceutical Teledetailing Program must have Multi-Channel Pharmaceutical Marketing approach. It includes fax, email, edetailing, direct mail and other channels. A multi-channel approach gives you the best chance at reaching all of your targets.

Read Original Source